Adaptive Biotechnologies IPO: Immune to Grow and Succeed; and the Future Looks Good
Adaptive Biotechnologies (ADPT US)Â has filed for an IPO in the US to raise approximately US$181m and has set an IPO price range of US$15-17 per...
472 Views
Personalis IPO: Personalising Cancer Trials and Treatments; Upside from Growth in Cancer Market
Personalis offers genomic sequencing to bio-pharmaceutical companies by fully analyzing sample tissue data of cancer patients. It provides its...
718 Views